Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 236

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 236
---
 fully paid warrant to purchase Company Shares. Each Company Warrant shall continue to have and be subject to substantially the same terms and conditions as were applicable to such SPAC Warrant immediately prior to the Merger Effective Time (including any repurchase rights and cashless exercise provisions) in accordance with the provisions of the SPAC Warrant Agreement and the Assignment, Assumption and Amendment Agreement. For more information on the Business Combination, see “ The Business Combination Agreement.” Basis of Presentation The adjustments presented on the pro forma combined financial statements have been identified and presented to provide an understanding of the Combined Company upon consummation of the Business Combination for illustrative purposes. The following unaudited pro forma combined consolidated financial information has been prepared in accordance with Article 11 of Regulation S -Xto depict the accounting for the transaction (the “Transaction Accounting Adjustments”). APx and OmnigenicsAI have elected not to present Management’s Adjustments and will only be presenting Transaction Accounting Adjustments in the following unaudited pro forma combined consolidated financial information. APx does not meet the definition of a “business” pursuant to IFRS3, Business Combinations, as it is a listed shell holding only cash raised as part of its original equity issuance. As a result, the portion of the Business Combination referring to the incorporation of APx does not qualify as a “business combination” within the meaning of IFRS3, Business Combinations; rather, said part of the Business Combination will be accounted for as a capital reorganization within the framework of a net asset acquisition. See “ Note 3 — Accounting for the Business Combination” for more details. The pro forma combined financial information is for illustrative purposes only. The financial results may have been different had the companies always been combined. You should not rely on the unaudited pro forma combined consolidated financial information as being indicative of the historical results that would have been achieved had the companies always been combined or the future results that the Combined Company will experience. SPAC and the Company have not had any intercompany transactions prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between the companies. The historical financial statements of the Company have been prepared in accordance with IFRS as issued by the IASB and in its presentation currency of the U.S. dollar. The historical financial statements of APx have been prepared in accordance with GAAP in its presentation currency of the U.S. dollar. The combined pro forma financial 103

information reflects IFRS, the basis